Inovio Pharmaceuticals Company Profile (NASDAQ:INO)

About Inovio Pharmaceuticals

Inovio Pharmaceuticals logoInovio Pharmaceuticals, Inc. (Inovio) is a bio-pharmaceutical company, which is involved in developing deoxyribonucleic acid (DNA) immunotherapies and vaccines focused on treating and preventing cancers and infectious diseases. The Company's DNA-based immunotherapies, in combination with its electroporation delivery devices, generates immune responses, in particular T cells, in the body to fight target diseases. It has completed, current or planned clinical programs of its SynCon immunotherapies for human papillomavirus (HPV)-caused pre-cancers and cancers, breast/lung/pancreatic cancer, hepatitis C virus (HCV), hepatitis B virus (HBV), human immunodeficiency virus (HIV), influenza, Ebola, Middle East respiratory syndrome (MERS) and Zika virus. With its immunotherapy platform, as well as with its CELLECTRA electroporation delivery technology, the Company has a pipeline of pre-clinical and clinical stage products that have generated in vivo (in the body) immune responses.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: INO
  • CUSIP:
Key Metrics:
  • Previous Close: $9.27
  • 50 Day Moving Average: $9.15
  • 200 Day Moving Average: $9.03
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -7.66
  • P/E Growth: 0.00
  • Market Cap: $681.79M
  • Outstanding Shares: 73,548,000
  • Beta: 2.63
Additional Links:
Companies Related to Inovio Pharmaceuticals:

Analyst Ratings

Consensus Ratings for Inovio Pharmaceuticals (NASDAQ:INO) (?)
Ratings Breakdown: 1 Hold Rating, 5 Buy Ratings
Consensus Rating:Buy (Score: 2.83)
Consensus Price Target: $18.33 (97.77% upside)

Analysts' Ratings History for Inovio Pharmaceuticals (NASDAQ:INO)
DateFirmActionRatingPrice TargetDetails
8/29/2016HC WainwrightInitiated CoverageBuy$17.00View Rating Details
8/18/2016Maxim GroupReiterated RatingHoldView Rating Details
8/8/2016Brean CapitalSet Price TargetBuy$18.00View Rating Details
8/8/2016Piper Jaffray Cos.Reiterated RatingOverweight$31.00View Rating Details
7/17/2016Stifel NicolausReiterated RatingBuy$13.00View Rating Details
6/21/2016Rodman & RenshawReiterated RatingBuy$17.00View Rating Details
(Data available from 8/30/2014 forward)


Earnings History for Inovio Pharmaceuticals (NASDAQ:INO)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
8/8/2016Q2($0.21)($0.26)$4.95 million$6.20 millionViewN/AView Earnings Details
5/9/2016Q1($0.14)($0.11)$4.75 million$8.10 millionViewN/AView Earnings Details
3/14/2016Q4($0.20)($0.25)$6.96 million$5.94 millionViewListenView Earnings Details
11/9/2015Q3$0.04$0.07$1.84 million$24.18 millionViewN/AView Earnings Details
8/10/2015Q215($0.13)($0.10)$5.52 million$5.30 millionViewListenView Earnings Details
5/11/2015Q1($0.11)($0.18)$7.04 million$5.20 millionViewListenView Earnings Details
3/16/2015Q414($0.10)($0.12)$5.24 million$2.50 millionViewN/AView Earnings Details
11/10/2014Q314($0.14)($0.12)$5.60 million$1.80 millionViewN/AView Earnings Details
8/11/2014Q214($0.19)($0.18)$1.80 million$3.80 millionViewN/AView Earnings Details
5/12/2014Q114($0.04)($0.05)$1.41 million$2.40 millionViewN/AView Earnings Details
3/17/2014Q413($0.03)($0.04)$1.36 million$1.70 millionViewN/AView Earnings Details
11/11/2013Q3($0.02)($0.16)$2.99 million$9.50 millionViewListenView Earnings Details
11/7/2012Q312($0.05)($0.05)$2.07 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Inovio Pharmaceuticals (NASDAQ:INO)
Current Year EPS Consensus Estimate: $-0.92 EPS
Next Year EPS Consensus Estimate: $-1.21 EPS


Dividend History for Inovio Pharmaceuticals (NASDAQ:INO)
No dividend announcements for this company have been tracked by

Insider Trades

Insider Trading History for Inovio Pharmaceuticals (NASDAQ:INO)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
6/28/2016Morton CollinsDirectorBuy10,000$9.13$91,300.00View SEC Filing  
5/18/2016Simon X BenitoDirectorSell6,250$10.37$64,812.50View SEC Filing  
4/15/2016Morton CollinsDirectorBuy68,400$9.52$651,168.00View SEC Filing  
9/30/2015Niranjan SardesaiCOOBuy4,000$5.50$22,000.00View SEC Filing  
8/14/2015Simon X BenitoDirectorBuy6,000$7.21$43,260.00View SEC Filing  
4/13/2015Angel CabreraDirectorBuy8,000$9.53$76,240.00View SEC Filing  
10/9/2014Peter KiesCFOBuy3,960$10.10$39,996.00View SEC Filing  
8/21/2014Morton CollinsDirectorBuy8,000$10.01$80,080.00View SEC Filing  
8/20/2014Morton CollinsDirectorBuy40,600$9.74$395,444.00View SEC Filing  
8/12/2014Jong Joseph KimCEOBuy250,000$9.06$2,265,000.00View SEC Filing  
8/12/2014Niranjan SardesaiCOOBuy2,550$8.70$22,185.00View SEC Filing  
4/15/2014Jong Joseph KimCEOBuy25,000$2.25$56,250.00View SEC Filing  
11/13/2013Morton CollinsDirectorBuy254,500$1.82$463,190.00View SEC Filing  
4/16/2013Mark BagarazziInsiderBuy60,000$0.56$33,600.00View SEC Filing  
4/2/2013Jong Joseph KimCEOBuy90,000$0.50$45,000.00View SEC Filing  
3/22/2013Angel CabreraDirectorBuy40,000$0.54$21,600.00View SEC Filing  
3/20/2013Jong Joseph KimCEOBuy60,000$0.53$31,800.00View SEC Filing  
3/20/2013Niranjan SardesaiCOOBuy25,000$0.53$13,250.00View SEC Filing  
1/15/2013Morton CollinsDirectorBuy100,000$0.67$67,000.00View SEC Filing  
11/14/2012Austin W & Greenhouse Da MarxeMajor ShareholderSell622,550$0.53$329,951.50View SEC Filing  
8/15/2012Angel CabreraDirectorBuy75,000$0.59$44,250.00View SEC Filing  
(Data available from 1/1/2013 forward)


Latest Headlines for Inovio Pharmaceuticals (NASDAQ:INO)
DateHeadline logoBuzz Stocks: Mylan NV, Inovio Pharmaceuticals Inc, and Herbalife Ltd. - Schaeffers Research (blog) (NASDAQ:INO) - August 29 at 5:30 PM logoInovio Pharma (INO) Commences Zika Vaccine Study in Puerto Rico - (NASDAQ:INO) - August 29 at 5:30 PM logoPennsylvania firm launches Zika vaccine trial in Puerto Rico (NASDAQ:INO) - August 29 at 5:30 PM logoInovio (INO) Stock Climbs, Launches Zika Vaccine Trial (NASDAQ:INO) - August 29 at 5:30 PM logoInovio: Let's Hear It For Zika! (NASDAQ:INO) - August 29 at 5:30 PM logoInovio launches second human study of potential Zika vaccine in Puerto Rico (NASDAQ:INO) - August 29 at 5:30 PM logoBRIEF-Inovio launches Zika vaccine trial (NASDAQ:INO) - August 29 at 10:10 AM logoInovio Unveils Zika Vaccine Trial In Midst Of Puerto Rico Epidemic (NASDAQ:INO) - August 29 at 10:10 AM logoInovio Pharma (INO) Commences Zika Vaccine Study in Puerto Rico (NASDAQ:INO) - August 29 at 10:10 AM logoInovio launches Zika vaccine trial in Puerto Rico (NASDAQ:INO) - August 29 at 10:10 AM logoInovio Launches Zika Vaccine Trial in Midst of Puerto Rico Epidemic to Explore Early Signals of Vaccine Efficacy (NASDAQ:INO) - August 29 at 10:10 AM logo3 Stocks to Watch on Monday: Ford Motor Company (F), General Motors Company (GM), Inovio Pharmaceuticals Inc (INO) (NASDAQ:INO) - August 29 at 8:28 AM
News IconInovio Expands Ebola Vaccine Trial (NASDAQ:INO) - August 25 at 10:39 AM
News IconInovio Expands Ebola Vaccine Trial INO (NASDAQ:INO) - August 25 at 10:39 AM
News IconInovio Pharmaceuticals, Inc. (INO) - Strategic and Financial SWOT Analysis Review (NASDAQ:INO) - August 24 at 5:31 PM
News IconInteresting INO Put And Call Options For October 21st (NASDAQ:INO) - August 23 at 10:01 AM logoWill Inovio Pharmaceuticals, Inc. (NASDAQ:INO) Hit $31 Price Target? - Investor Newswire (NASDAQ:INO) - August 22 at 10:14 AM logo3 Reasons Inovio Pharmaceuticals Inc. Stock Could Rise -- The ... - Motley Fool (NASDAQ:INO) - August 20 at 9:51 AM
News IconHC Stocks Overview: Inovio Pharmaceuticals Inc (NASDAQ:INO), Allergan plc Ordinary Shares (NYSE:AGN) - share market updates (press release) (NASDAQ:INO) - August 18 at 5:42 PM
News IconInovio Pharma licenses veterinary vaccine for FMD to Plumbline Life Sciences (NASDAQ:INO) - August 18 at 8:39 AM logoInovio licenses experimental veterinary vaccine to South Korean firm (NASDAQ:INO) - August 18 at 8:39 AM logoInovio Pharmaceuticals : Licenses Veterinary Foot and Mouth Disease Vaccine to Plumbline Life Sciences (NASDAQ:INO) - August 18 at 8:39 AM
News IconBetter Buy: Novavax, Inc. vs. Inovio Pharmaceuticals - (NASDAQ:INO) - August 17 at 5:51 PM logoINOVIO PHARMACEUTICALS, INC. Financials (NASDAQ:INO) - August 16 at 5:49 PM logo8:03 am Inovio Pharma licenses a veterinary vaccine for foot and mouth disease to Plumbline Life Sciences, co in South Korea (NASDAQ:INO) - August 16 at 12:03 PM logoInovio Licenses Veterinary Foot and Mouth Disease Vaccine to Plumbline Life Sciences (NASDAQ:INO) - August 16 at 12:03 PM logoETF’s with exposure to Inovio Pharmaceuticals, Inc. : August 15, 2016 (NASDAQ:INO) - August 15 at 3:29 PM logoInovio Expands Enrollment in Ebola Vaccine Phase I Study (NASDAQ:INO) - August 15 at 3:29 PM logoObama Moves Money Around To Keep Zika Research Going Amid Lack Of Congressional Funds Allocation (NASDAQ:INO) - August 12 at 5:43 PM logoWhat HC Wainwright Thinks of Inovio Pharmaceuticals Inc (INO) Following 2Q Results - Smarter Analyst (NASDAQ:INO) - August 12 at 8:50 AM logoMaxim Comments on Inovio Pharmaceuticals Inc (INO) as Ebola Vaccine Study Expands - Smarter Analyst (NASDAQ:INO) - August 12 at 8:50 AM logoThe Biotech Round-Up: Valeant Pharmaceuticals Intl Inc (VRX), Inovio Pharmaceuticals Inc (INO), Synergy ... - Smarter Analyst (NASDAQ:INO) - August 11 at 5:55 PM logoBetter Buy: Inovio Pharmaceuticals, Inc. vs. Incyte Corporation -- The ... - Motley Fool (NASDAQ:INO) - August 11 at 5:55 PM logoBRIEF-Inovio expands positive Phase I Ebola vaccine trial (NASDAQ:INO) - August 11 at 8:40 AM logoInovio Pharmaceuticals Expands Positive Phase I Ebola Vaccine Trial to Identify Most Optimal Immunization Regimen (NASDAQ:INO) - August 11 at 8:39 AM logoInovio Pharmaceuticals, Inc. :INO-US: Earnings Analysis: Q2, 2016 By the Numbers : August 10, 2016 (NASDAQ:INO) - August 10 at 5:55 PM logoAnalyst Views To Note: Inovio Pharmaceuticals Inc (NASDAQ:INO), Rayonier Advanced Materials Inc (NYSE:RYAM) - Review Fortune (NASDAQ:INO) - August 10 at 8:34 AM logoInovio Pharma May Be Burning Too Hot - Barron's (NASDAQ:INO) - August 10 at 8:34 AM
News IconNews Fact on Vanguard Level- Fluor (NYSE:FLR), Inovio Pharmaceuticals (NASDAQ:INO), Graphic Packaging (NYSE ... - Seneca Globe (NASDAQ:INO) - August 9 at 5:50 PM
News IconIntegrated Device Technology (NASDAQ:IDTI) & Inovio Pharmaceuticals (NASDAQ:INO) Stocks Intraday Alert - Money News (press release) (NASDAQ:INO) - August 9 at 5:50 PM logoInovio Pharmaceuticals Inc. (INO) Drops 5.08% on August 08 - (NASDAQ:INO) - August 9 at 5:50 PM logoZika Threat: GlaxoSmithKline plc (GSK), Inovio Pharmaceuticals Inc (INO), Sanofi SA (SNY); What Are The Options - TCC (NASDAQ:INO) - August 9 at 5:50 PM logoInovio Pharma Shares Higher As Q2 Sales Beat (NASDAQ:INO) - August 9 at 8:40 AM logoGeneOne Life Science Announces Full Enrollment of First-In-Human Study of MERS Vaccine (NASDAQ:INO) - August 9 at 8:40 AM logoStrong Sell Calls For Inovio Pharmaceuticals, Inc. (NASDAQ:INO) At 0 - Investor Newswire (NASDAQ:INO) - August 8 at 5:51 PM
News IconHC Stocks in Hub: Inovio Pharmaceuticals Inc (NASDAQ:INO ... - share market updates (press release) (NASDAQ:INO) - August 8 at 5:51 PM logoInovio Pharma Shares Higher As Q2 Sales Beat - Benzinga (NASDAQ:INO) - August 8 at 5:51 PM logoInovio (INO) Stock Slumps After Mixed Q2 Results (NASDAQ:INO) - August 8 at 5:51 PM
News IconInovio Pharma appoints Dr Ami Shah Brown as vice president regulatory affairs (NASDAQ:INO) - August 8 at 10:21 AM logoEARNINGS SUMMARY: Details of Inovio Pharmaceuticals Inc. Q2 Earnings Report (NASDAQ:INO) - August 8 at 10:21 AM


Inovio Pharmaceuticals (NASDAQ:INO) Chart for Tuesday, August, 30, 2016

Last Updated on 8/30/2016 by Staff